Under Reported

The Next Waltz Is naltrexone the next drug to change the course of the HIV pandemic? by Jeannie Wraight A recent study showed one potential intervention, naltrexone,...

Color Blind A new report documents racism and xenophobia in HIV non-disclosure media coverage in Canada by Larry Buhl A new report documents the anti-Black and anti-immigrant...

Working Toward Balance Research into treating the effects of microbes gains steam by Jeannie Wraight There’s been lots of talk recently about the importance of microbes on...

LifeGuide Military Medicine Two leaders on the front lines of HIV research often go unrecognized by Mariel Selbovitz, MPH The U.S. is the global leader in the fight...

Rural HEROES A first-of-its-kind report reveals HIV-related needs in underserved nonmetropolitan Louisiana by Chael Needle We can’t end the HIV/AIDS crisis without ending it in the rural...

Approximately thirty to sixty percent of people living with HIV and on antiretroviral therapy (ARVs) experience diarrhea. Reoccurring and frequent diarrhea is often reluctantly...

Dreaming of the Cells We Had We Need to Bring Immune-Based Therapies Off of the Sidelines by Jeannie Wraight For most people living with HIV, antiretrovirals (ARVs)...

PrEP Care Howard Brown Health Improves Access to HIV Prevention by Chael Needle The United States Preventive Services Task Force (USPSTF) recently issued its final “A” grade...

It happens every five years. The United Nations General Assembly convenes high-level meetings on HIV/AIDS to review progress on the epidemic and draw attention...